← Browse by Condition
Medical Condition
squamous cell carcinoma of head and neck
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 1, Phase 2, Phase 2, Phase 1
ClinicalMetric tracks all active clinical trials for squamous cell carcinoma of head and neck sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — squamous cell carcinoma of head and neck Clinical Trials
How many clinical trials are currently recruiting for squamous cell carcinoma of head and neck?
ClinicalMetric currently tracks 6 actively recruiting clinical trials for squamous cell carcinoma of head and neck, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 6. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for squamous cell carcinoma of head and neck?
squamous cell carcinoma of head and neck research spans Phase 1 (4 trials), Phase 2 (4 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a squamous cell carcinoma of head and neck clinical trial?
Eligibility criteria for squamous cell carcinoma of head and neck trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 4
Phase 2 4
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06385080 Phase 1, Phase 2
Recruiting
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
Enrollment
287 pts
Location
United States, China...
Sponsor
Janssen Research & Development...
NCT05086692 Phase 1, Phase 2
Recruiting
A Beta-only IL-2 ImmunoTherapY Study
Enrollment
115 pts
Location
United States, Austr...
Sponsor
Medicenna Therapeutics, Inc.
NCT07055841 Phase 2
Recruiting
Single-Arm Exploratory Study of PD-L1 Antibody Plus Neoadjuvant Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
Enrollment
69 pts
Location
China
Sponsor
Xiuping Ding
NCT04895709 Phase 1, Phase 2
Recruiting
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
Enrollment
949 pts
Location
United States, Austr...
Sponsor
Bristol-Myers Squibb
NCT07219212 Phase 1
Recruiting
A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma
Enrollment
30 pts
Location
United States, Franc...
Sponsor
Johnson & Johnson Enterprise I...
NCT06367257
Recruiting
App-based Recording and Optimization of the Nutritional Status in Patients With Head and Neck Tumors During and After Radio(Chemo)Therapy
Enrollment
148 pts
Location
Germany
Sponsor
University of Erlangen-Nürnber...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology